Avet-Loiseau, Herve
Facon, Thierry
Article History
Received: 12 December 2017
Revised: 12 February 2018
Accepted: 15 February 2018
First Online: 28 March 2018
Compliance with ethical standards
:
: HA-L declares that he has no conflict of interest; TF reports advisory board fees from Amgen, Celgene, Janssen, Karyopharm, Pharmamar, and Takeda and speakers bureau fees from Amgen, Celgene, Janssen, and Takeda.